The Evidence Base Post 29 October 2026 A dual mandate for branded drug prices Melanie D Whittington & Jonathan D Campbell Register with The Evidence Base for free to access this content Already have an account? Sign in By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.